MedTrace Logo

Impact of Vitamin D Supplementation on COVID-19 Vaccine Response and IgG Antibodies in Deficient Women.

NCT05447065 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2022-09-28

No results posted yet for this study

Summary

Decreased immunity in individuals causes a decrease in vaccine response, and vitamin D worsens this course. Vitamin D is thought to be a vitamin that can strengthen the innate immune response, inhibit the adaptive system, and modulate the vaccine response.

The effect of vitamin D intake on antibodies was studied.

Conditions

  • COVID-19 Pandemic
  • D Vitamin Deficiency
  • Antibody Hypersensitivity

Interventions

DIETARY_SUPPLEMENT

Vitamin D supplement

Only the experimental group (D) received the vitamin D supplement.

Sponsors & Collaborators

  • Avrasya University

    collaborator OTHER

  • Ege University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
23 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-05-07
Primary Completion
2022-06-10
Completion
2022-07-07

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05447065 on ClinicalTrials.gov